Enrofloxacin 100 mg/mL provides flexible dosages and durations of therapy.
Enrofloxacin 100 mg/mL may be administered as a single dose for one day for treatment and control of BRD (cattle), for treatment and control of SRD or for control of colibacillosis (swine), or for multiple days for BRD treatment (cattle). Selection of the appropriate dose and duration of therapy for BRD treatment in cattle should be based on an assessment of the severity of the disease, pathogen susceptibility and clinical response.
Cattle:
Single-Dose Therapy (BRD Treatment): Administer, by subcutaneous injection, a single dose of 7.5-12.5 mg/kg of body weight (3.4-5.7 mL/100 lb).
Multiple-Day Therapy (BRD Treatment): Administer daily, a subcutaneous dose of 2.5-5 mg/kg of body weight (1.1-2.3 mL/100 lb). Treatment should be repeated at 24-hour intervals for three days. Additional treatments may be given on Days 4 and 5 to animals that have shown clinical improvement but not total recovery.
Single-Dose Therapy (BRD Control): Administer, by subcutaneous injection, a single dose of 7.5 mg/kg of body weight (3.4 mL/100 lb). Examples of conditions that may contribute to calves being at high risk of developing BRD include, but are not limited to, the following:
Transportation with animals from two or more farm origins.
An extended transport time with few to no rest stops.
An environmental temperature change of ≥30°F during transportation.
A ≥30°F range in temperature fluctuation within a 24-hour period.
Exposure to wet or cold weather conditions.
Excessive shrink (more than would be expected with a normal load of cattle).
Stressful arrival processing procedures (e.g., castration or dehorning).
Exposure within the prior 72 hours to animals showing clinical signs of BRD.
Administered dose volume should not exceed 20 mL per injection site.
Table 1 - Enrofloxacin 100 mg/mL Dose and Treatment Schedule for Cattle*
Weight(lb)
Treatment
Control
Single-Dose Therapy 7.5-12.5 mg/kg Dose Volume (mL)
Multiple-Day Therapy 2.5-5.0 mg/kg DoseVolume(mL)
Single-Dose Therapy 7.5 mg/kg Dose Volume (mL)
100
3.5 - 5.5
1.5 - 2.0
3.5
200
7.0 - 11.0
2.5 - 4.5
7.0
300
10.5 - 17.0
3.5 - 6.5
10.5
400
14.0 - 22.5
4.5 - 9.0
14.0
500
17.0 - 28.5
5.5 - 11.5
17.0
600
20.5 - 34.0
7.0 - 13.5
20.5
700
24.0 - 39.5
8.0 - 16.0
24.0
800
27.5 - 45.5
9.0 - 18.0
27.5
900
31.0 - 51.0
10.0 - 20.5
31.0
1000
34.0 - 57.0
11.0 - 23.0
34.0
1100
37.5 - 62.5
12.5 - 25.0
37.5
*Dose volumes have been rounded to the nearest 0.5 mL within the dose range.
Swine:
Administer, either by intramuscular or subcutaneous (behind the ear) injection, a single dose of 7.5 mg/kg of body weight (3.4 mL/100 lb). Administered dose volume should not exceed 5 mL per injection site.
For the control of colibacillosis, administration should be initiated within the first 60 days post-weaning when clinical signs are present in at least 2% of the animals in the group. If no improvement is noted within 48 hours, the diagnosis should be reevaluated.
Table 2- Enrofloxacin 100 mg/mL Dose Schedule for Swine
Weight (lb)
Dose Volume (mL)
15
0.5
30
1.0
50
1.7
100
3.4
150
5.1
200
6.8
250
8.5
Dilution of Enrofloxacin 100 mg/mL: Enrofloxacin 100 mg/mL may be diluted with sterile water prior to injection. The diluted product should be used within 24 hours. Store diluted solution in amber glass bottles between 4-40°C (36-104°F).
Table 3 – Dilution Schedule*
Swine Weight
mL of Enrofloxacin 100 mg/mL
mL of sterile water
Number of doses
10 lb
34 mL
66 mL
100
15 lb
51 mL
49 mL
100
20 lb
68 mL
32 mL
100
25 lb
85 mL
15 mL
100
*For 1 mL dose volume from diluted solution
Use within 30 days of first puncture and puncture a maximum of 30 times. If more than 30 punctures are anticipated, the use of multi-dosing equipment is recommended. When using a draw-off spike or needle with bore diameter larger than 16- gauge, discard any product remaining in the vial immediately after use.
SUBCUTANEOUS, INTRAMUSCULAR
Enrofloxacin 100 mg/mL Antimicrobial Injectable Solution
DOSAGE AND ADMINISTRATION:
Quellaxcin™ 100 provides flexible dosages and durations of therapy.
Quellaxcin™ 100 may be administered as a single dose for one day for treatment and control of BRD (cattle), for treatment and control of SRD or for control of colibacillosis (swine), or for multiple days for BRD treatment (cattle). Selection of the appropriate dose and duration of therapy for BRD treatment in cattle should be based on an assessment of the severity of the disease, pathogen susceptibility and clinical response.
Cattle:
Single-Dose Therapy (BRD Treatment): Administer, by subcutaneous injection, a single dose of 7.5-12.5 mg/kg of body weight (3.4-5.7 mL/100 lb).
Multiple-Day Therapy (BRD Treatment): Administer daily, a subcutaneous dose of 2.5-5 mg/kg of body weight (1.1-2.3 mL/100 lb). Treatment should be repeated at 24-hour intervals for three days. Additional treatments may be given on Days 4 and 5 to animals that have shown clinical improvement but not total recovery.
Single-Dose Therapy (BRD Control): Administer, by subcutaneous injection, a single dose of 7.5 mg/kg of body weight (3.4 mL/100 lb). Examples of conditions that may contribute to calves being at high risk of developing BRD include, but are not limited to, the following:
Transportation with animals from two or more farm origins.
An extended transport time with few to no rest stops.
An environmental temperature change of 30°F during transportation.
A 30°F range in temperature fluctuation within a 24-hour period.
Exposure to wet or cold weather conditions.
Excessive shrink (more than would be expected with a normal load of cattle).
Stressful arrival processing procedures (e.g., castration or dehorning).
Exposure within the prior 72 hours to animals showing clinical signs of BRD.
Administered dose volume should not exceed 20 mL per injection site.
Table 1 – Quellaxcin™ 100
100 Dose and Treatment Schedule for Cattle*
*Dose volumes have been rounded to the nearest 0.5 mL within the dose range.
Weight
(lb)
Treatment
Control
Single-Dose Therapy
7.5 - 12.5 mg/kg
Dose Volume (mL)
Multiple-Day Therapy
2.5 - 5.0 mg/kg
Dose Volume (mL)
Single-Dose Therapy
7.5 mg/kg
Dose Volume (mL)
100
3.5 - 5.5
1.5 - 2.0
3.5
200
7.0 - 11.0
2.5 - 4.5
7.0
300
10.5 - 17.0
3.5 - 6.5
10.5
400
14.0 - 22.5
4.5 - 9.0
14.0
500
17.0 - 28.5
5.5 - 11.5
17.0
600
20.5 - 34.0
7.0 - 13.5
20.5
700
24.0 - 39.5
8.0 - 16.0
24.0
800
27.5 - 45.5
9.0 - 18.0
27.5
900
31.0 - 51.0
10.0 - 20.5
31.0
1000
34.0 - 57.0
11.0 - 23.0
34.0
1100
37.5 - 62.5
12.5 - 25.0
37.5
Swine:
Administer, either by intramuscular or subcutaneous (behind the ear) injection, a single dose of 7.5 mg/kg of body weight (3.4 mL/100 lb).
Administered dose volume should not exceed 5 mL per injection site.
For the control of colibacillosis, administration should be initiated within the first 60 days post-weaning when clinical signs are present in at least 2% of the animals in the group. If no improvement is noted within 48 hours, the diagnosis should be reevaluated.
Table 2 - Quellaxcin™ 100 Dose Schedule for Swine
Weight (lb)
Dose Volume (mL)
15
0.5
30
1.0
50
1.7
100
3.4
150
5.1
200
6.8
250
8.5
Dilution of Quellaxcin™100: Quellaxcin™ 100 may be diluted with sterile water prior to injection. Discard any diluted product remaining in the vial immediately after use.
Table 3 – Dilution Schedule*
Swine Weight
mL of Quellaxcin™ 100
mL of Sterile Water
Number of Doses
10 lb
34 mL
66 mL
100
15 lb
51 mL
49 mL
100
20 lb
68 mL
32 mL
100
25 lb
85 mL
15 mL
100
* For 1 mL dose volume from diluted solution
Use within 28 days of first puncture and puncture a maximum of 25 times with a needle or 5 times with a dosage delivery device.
SUBCUTANEOUS, INTRAMUSCULAR
QuellaxcinTM 100(enrofloxacin)
DOSAGE AND ADMINISTRATION:
EnroMed™ 100 provides flexible dosages and durations of therapy.
EnroMed™ 100 may be administered as a single dose for one day for treatment and control of BRD (cattle), for treatment and control of SRD or for control of colibacillosis (swine), or for multiple days for BRD treatment (cattle). Selection of the appropriate dose and duration of therapy for BRD treatment in cattle should be based on an assessment of the severity of the disease, pathogen susceptibility and clinical response.
Cattle:
Single-Dose Therapy (BRD Treatment): Administer, by subcutaneous injection, a single dose of 7.5-12.5 mg/kg of body weight (3.4-5.7 mL/100 lb).
Multiple-Day Therapy (BRD Treatment): Administer daily, a subcutaneous dose of 2.5-5 mg/kg of body weight (1.1-2.3 mL/100 lb). Treatment should be repeated at 24-hour intervals for three days. Additional treatments may be given on Days 4 and 5 to animals that have shown clinical improvement but not total recovery.
Single-Dose Therapy (BRD Control): Administer, by subcutaneous injection, a single dose of 7.5 mg/kg of body weight (3.4 mL/100 lb). Examples of conditions that may contribute to calves being at high risk of developing BRD include, but are not limited to, the following:
Transportation with animals from two or more farm origins.
An extended transport time with few to no rest stops.
An environmental temperature change of 30°F during transportation.
A 30°F range in temperature fluctuation within a 24-hour period.
Exposure to wet or cold weather conditions.
Excessive shrink (more than would be expected with a normal load of cattle).
Stressful arrival processing procedures (e.g., castration or dehorning).
Exposure within the prior 72 hours to animals showing clinical signs of BRD.
Administered dose volume should not exceed 20 mL per injection site.
Table 1 –EnroMed™ 100
100 Dose and Treatment Schedule for Cattle
*
*Dose volumes have been rounded to the nearest 0.5 mL within the dose range.
Weight
(lb)
Treatment
Control
Single-Dose Therapy
7.5 - 12.5 mg/kg
Dose Volume (mL)
Multiple-Day Therapy
2.5 - 5.0 mg/kg
Dose Volume (mL)
Single-Dose Therapy
7.5 mg/kg
Dose Volume (mL)
100
3.5 - 5.5
1.5 - 2.0
3.5
200
7.0 - 11.0
2.5 - 4.5
7.0
300
10.5 - 17.0
3.5 - 6.5
10.5
400
14.0 - 22.5
4.5 - 9.0
14.0
500
17.0 - 28.5
5.5 - 11.5
17.0
600
20.5 - 34.0
7.0 - 13.5
20.5
700
24.0 - 39.5
8.0 - 16.0
24.0
800
27.5 - 45.5
9.0 - 18.0
27.5
900
31.0 - 51.0
10.0 - 20.5
31.0
1000
34.0 - 57.0
11.0 - 23.0
34.0
1100
37.5 - 62.5
12.5 - 25.0
37.5
Swine:
Administer, either by intramuscular or subcutaneous (behind the ear) injection, a single dose of 7.5 mg/kg of body weight (3.4 mL/100 lb).
Administered dose volume should not exceed 5 mL per injection site.
For the control of colibacillosis, administration should be initiated within the first 60 days post-weaning when clinical signs are present in at least 2% of the animals in the group. If no improvement is noted within 48 hours, the diagnosis should be reevaluated.
Table 2 - EnroMed™ 100 Dose Schedule for Swine
Weight (lb)
Dose Volume (mL)
15
0.5
30
1.0
50
1.7
100
3.4
150
5.1
200
6.8
250
8.5
Use within 28 days of first puncture and puncture a maximum of 25 times with a needle or 5 times with a dosage delivery device.
Dilution of EnroMed™100: EnroMed™ 100 may be diluted with sterile water prior to injection. Discard any diluted product remaining in the vial immediately after use.
Table 3 – Dilution Schedule*
Swine Weight
mL of EnroMed™100
mL of Sterile Water
Number of Doses
10 lb
34 mL
66 mL
100
15 lb
51 mL
49 mL
100
20 lb
68 mL
32 mL
100
25 lb
85 mL
15 mL
100
* For 1 mL dose volume from diluted solution
SUBCUTANEOUS, INTRAMUSCULAR
FDA application 200-598
Tenotryl™ provides flexible dosages and durations of therapy. Tenotryl™ may be administered as a single dose for one day for treatment and control of BRD (cattle), for treatment and control of SRD or for control of colibacillosis (swine), or for multiple days for BRD treatment (cattle). Selection of the appropriate dose and duration of therapy for BRD treatment in cattle should be based on an assessment of the severity of the disease, pathogen susceptibility and clinical response.
Cattle:
Single-Dose Therapy (BRD Treatment): Administer, by subcutaneous injection, a single dose of 7.5-12.5 mg/kg of body weight (3.4-5.7 mL/100 lb).
Multiple-Day Therapy (BRD Treatment): Administer daily, a subcutaneous dose of 2.5-5 mg/kg of body weight (1.1-2.3 mL/100 lb).Treatment should be repeated at 24-hour intervals for three days. Additional treatments may be given on Days 4 and 5 to animals that have shown clinical improvement but not total recovery.
Single-Dose Therapy (BRD Control): Administer, by subcutaneous injection, a single dose of 7.5 mg/kg of body weight (3.4 mL/100 lb).Examples of conditions that may contribute to calves being at high risk of developing BRD include, but are not limited to, the following:
• Transportation with animals from two or more farm origins.
• An extended transport time with few to no rest stops.
• An environmental temperature change of ≥30°F during transportation.
• A ≥30°F range in temperature fluctuation within a 24-hour period.
• Exposure to wet or cold weather conditions.
• Excessive shrink (more than would be expected with a normal load of cattle).
• Stressful arrival processing procedures (e.g., castration or dehorning).
• Exposure within the prior 72 hours to animals showing clinical signs of BRD.
Administered dose volume should not exceed 20 mL per injection site.
Swine:
Administer, either by intramuscular or subcutaneous (behind the ear) injection, a single dose of 7.5 mg/kg of body weight (3.4 mL/100 lb). Administered dose volume should not exceed 5 mL per injection site. For the control of colibacillosis, administration should be initiated within the first 60 days post-weaning when clinical signs are presenting at least 2% of the animals in the group. If no improvement is noted within 48 hours, the diagnosis should be reevaluated.
Dilution of Tenotryl:
Tenotryl™ may be diluted with sterile water prior to injection. The diluted product should be used within 24 hours. Store diluted solution in amber glass bottles between 5°C - 40°C (41°F – 104°F), excursions are not permitted.
Use within 30 days of first puncture and puncture a maximum of 30times with a 16-gauge needle or smaller, or 4 times with a draw-off spike 4.75 mm or smaller. Any product remaining beyond these parameters should be discarded.
SUBCUTANEOUS, INTRAMUSCULAR
Tenotryl™ (enrofloxacin)100 mg/mL Antimicrobial Injectable Solution
Dogs: Administer orally at a rate to provide 5-20 mg/kg (2.27 to 9.07 mg/lb) of body weight. Selection of a dose within the range should be based on clinical experience, the severity of disease, and susceptibility of the pathogen. Animals which receive doses in the upper-end of the dose range should be carefully monitored for clinical signs that may include inappetence, depression, and vomition. If dogs do not consume Enrofloxacin Flavored Tablets willingly when offered by hand, then alternatively the tablet(s) may be offered in the food or hand- administered (pilled) as with other oral tablet medications.
Weight of Dog
Once Daily Dosing Chart
5.0 mg/kg
10.0 mg/kg
15.0 mg/kg
20.0 mg/kg
9.1 kg (20 lb)
2 x 22.7 mg tablets
1 x 22.7 mg plus
1 x 68 mg tablets
1 x 136 mg tablet
1 x 136 mg plus
2 x 22.7 mg tablets
27.2 kg (60 lb)
1 x 136 mg tablets
2 x 136 mg tablets
3 x 136 mg tablets
4 x 136 mg tablets
All tablet sizes are double scored for accurate dosing.
Cats: Administer orally at 5 mg/kg (2.27 mg/lb) of body weight. The dose for dogs and cats may be administered either as a single daily dose or divided into two (2) equal daily doses administered at twelve (12) hour intervals. The dose should be continued for at least 2-3 days beyond cessation of clinical signs, to a maximum of 30 days. In cats, Enrofloxacin Flavored Tablets should be pilled. After adminsitration, watch the animal closely to be certain the entire dose has been consumed.
Weight of Cat
Once Daily Dosing Chart (5 mg/kg/day)
5 lb (2.27 kg)
1/2 x 22.7 mg tablet
10 lb (4.5 kg)
1 x 22.7 mg tablet
15 lb (6.8 kg)
1 and 1/2 x 22.7 mg tablets or 1/2 x 68 mg tablet
All tablet sizes are double scored for accurate dosing.
Dogs & Cats: The duration of treatment should be selected based on clinical evidence.
Generally, administration of Enrofloxacin Flavored Tablets should continue for at least 2-3 days beyond cessation of clinical signs. For severe and/or complicated infections, more prolonged therapy, up to 30 days, may be required. If no improvement is seen within five days, the diagnosis should be re-evaluated and a different course of therapy considered.
The lower limit of the dose range in dogs and the daily dose for cats was based on efficacy studies in dogs and cats where enrofloxacin was administered at 2.5 mg/kg twice daily. Target animal safety and toxicology were used to establish the upper limit of the dose range for dogs and treatment duration for dogs and cats.
ORAL
FDA application 200-680
Dogs: Administer orally at a rate to provide 5-20 mg/kg (2.27 to 9.07 mg/lb) of body weight. Selection of a dose within the range should be based on clinical experience, the severity of disease, and susceptibility of the pathogen. Animals which receive doses in the upper-end of the dose range should be carefully monitored for clinical signs that may include inappetence, depression, and vomition.
All tablet sizes are double scored for accurate dosing.
Weight
of
Dog
Once Daily Dosing Chart
5.0 mg/kg
10.0 mg/kg
15.0 mg/kg
20.0 mg/kg
9.1 kg
(20 lb)
2 x 22.7 mg
tablets
1 x 22.7 mg plus
1 x 68 mg tablets
1 x 136 mg
tablet
1 x 136 mg plus
2 x 22.7 mg tablets
27.2 kg
(60 lb)
1 x 136 mg
tablet
2 x 136 mg
tablets
3 x 136 mg
tablets
4 x 136 mg
tablets
Cats: Administer orally at 5 mg/kg (2.27 mg/lb) of body weight. The dose for dogs and cats may be administered either as a single daily dose or divided into two (2) equal daily doses administered at twelve (12) hour intervals. The dose should be continued for at least 2-3 days beyond cessation of clinical signs, to a maximum of 30 days.
All tablet sizes are double scored for accurate dosing.
Weight
of Cat
Once Daily Dosing Chart
(5 mg/kg/day)
5 lb
(2.27 kg)
1/2 x 22.7 mg tablet
10 lb
(4.5 kg)
1 x 22.7 mg tablet
15 lb
(6.8 kg)
1 and 1/2 x 22.7 mg tablets or
1/2 x 68 mg tablet
Palatability: Most dogs will consume Baytril Taste Tabs Tablets willingly when offered by hand. Alternatively the tablet(s) may be offered in food or hand-administered (pilled) as with other oral tablet medications. In cats, Baytril Taste Tabs Tablets should be pilled. After administration, watch the animal closely to be certain the entire dose has been consumed.
Dogs & Cats: The duration of treatment should be selected based on clinical evidence. Generally, administration of Baytril Tablets should continue for at least 2-3 days beyond cessation of clinical signs. For severe and/or complicated infections, more prolonged therapy, up to 30 days, may be required. If no improvement is seen within five days, the diagnosis should be reevaluated and a different course of therapy considered.
The lower limit of the dose range in dogs and the daily dose for cats was based on efficacy studies in dogs and cats where enrofloxacin was administered at 2.5 mg/kg twice daily. Target animal safety and toxicology were used to establish the upper limit of the dose range for dogs and treatment duration for dogs and cats.
ORAL
Approved by FDA under NADA # 140-441 Elanco TM BaytrilTM (enrofloxacin) Taste TabsTM 22.7 mg, 68 mg, 136 mg Antibacterial Tablets For Dogs And Cats
Dogs: Administer orally at a rate to provide 5-20 mg/kg (2.27 to 9.07 mg/lb) of body weight. Selection of a dose within the range should be based on clinical experience, the severity of disease, and susceptibility of the pathogen. Animals which receive doses in the upper-end of the dose range should be carefully monitored for clinical signs that may include inappetence, depression, and vomition.
Weight of Dog
Once Daily Dosing Chart
5.0 mg/kg
10.0 mg/kg
15.0 mg/kg
20.0 mg/kg
9.1 kg (20 lb)
2 x 22.7 mg tablets
1 x 22.7 mg plus
1 x 68 mg tablets
1 x 136 mg tablet
1 x 136 mg plus
2 x 22.7 mg tablets
27.2 kg (60 lb)
1 x 136 mg tablet
2 x 136 mg tablets
3 x 136 mg tablets
4 x 136 mg tablets
All tablet sizes are double scored for accurate dosing.
Cats: Administer orally at 5 mg/kg (2.27 mg/lb) of body weight. The dose for dogs and cats may be administered either as a single daily dose or divided into two (2) equal daily doses administered at twelve (12) hour intervals. The dose should be continued for at least 2-3 days beyond cessation of clinical signs, to a maximum of 30 days.
Weight of Cat
Once Daily Dosing Chart
(5 mg/kg/day)
5 lb (2.27 kg)
1/2 x 22.7 mg tablet
10 lb (4.5 kg)
1 x 22.7 mg tablet
15 lb (6.8 kg)
1 and 1/2 x 22.7 mg tablets or 1/2 x 68 mg tablet
All tablet sizes are double scored for accurate dosing.
Palatability: Enrofloxacin flavored tablets may be offered to dogs by hand. Alternatively the tablets may be offered in food or hand-administered (pilled) as with other oral tablet medications. In cats, enrofloxacin flavored tablets should be pilled. After administration, watch the animal closely to be certain the entire dose has been consumed.
Dogs & Cats: The duration of treatment should be selected based on clinical evidence.
Generally, administration of enrofloxacin tablets should continue for at least 2-3 days beyond cessation of clinical signs. For severe and/or complicated infections, more prolonged therapy, up to 30 days, may be required. If no improvement is seen within five days, the diagnosis should be re-evaluated and a different course of therapy considered.
The lower limit of the dose range in dogs and the daily dose for cats was based on efficacy studies in dogs and cats where enrofloxacin was administered at 2.5 mg/kg twice daily. Target animal safety and toxicology were used to establish the upper limit of the dose range for dogs and treatment duration for dogs and cats.
ORAL
FDA application 200-737
EnroProTM 22.7 Injectable Solution may be used as the initial dose at 2.5 mg/kg. It should be administered intramuscularly (IM) as a single dose, followed by initiation of enrofloxacin tablet therapy.
EnroProTM 22.7 Injectable Solution may be administered as follows:
Weight of Animal
EnroProTM 22.7 Injectable Solution* 2.5 mg/kg
9.1 kg (20 lb)
1.00 mL
27.2 kg (60 lb)
3.00 mL
*The initial EnroPro
TM
22.7 Injectable administration should be followed 12 hours later by initiation of enrofloxacin tablet therapy.
The lower limit of the dose range was based on efficacy studies in dogs where enrofloxacin was administered at 2.5 mg/kg twice daily. Target animal safety and toxicology studies were used to establish the upper limit of the dose range and treatment duration.
INTRAMUSCULAR
EnroPro TM 22.7(enrofloxacin)Antibacterial Injectable Solution 2.27%For Dogs Only
DOSAGE AND ADMINISTRATION:
Enroquin Injectable Solution may be used as the initial dose at 2.5 mg/kg. It should be administered intramuscularly (IM) as a single dose, followed by initiation of enrofloxacin tablet therapy.
Enroquin Injectable Solution may be administered as follows:
Weight of Animal
Enroquin Injectable SolutionThe initial Enroquin injectable administration should be followed 12 hours later by initiation of enrofloxacin tablet therapy. 2.5 mg/kg
9.1 kg
(20 lb)
1.00 mL
27.2 kg
(60 lb)
3.00 mL
The lower limit of the dose range was based on efficacy studies in dogs where enrofloxacin was administered at 2.5 mg/kg twice daily. Target animal safety and toxicology studies were used to establish the upper limit of the dose range and treatment duration.
INTRAMUSCULAR
Enroquin® (enrofloxacin)
Enrofloxacin Injectable Solution may be used as the initial dose at 2.5 mg/kg. It should be administered intramuscularly (IM) as a single dose, followed by initiation of enrofloxacin tablet therapy.
Enrofloxacin Injectable Solution may be administered as follows:
Weight of
Animal
Enrofloxacin
Injectable Solution*
2.5 mg/kg
9.1 kg (20 lb)
1.00 mL
27.2 kg (60 lb)
3.00 mL
* The initial enrofloxacin injectable administration should be followed 12 hours later by initiation of enrofloxacin tablet therapy.
The lower limit of the dose range was based on efficacy studies in dogs where enrofloxacin was administered at 2.5 mg/kg twice daily. Target animal safety and toxicology studies were used to establish the upper limit of the dose range and treatment duration.
INTRAMUSCULAR
NDC No. 11695-6999-1 Enrofloxacin Antibacterial Injectable Solution 2.27% For Dogs Only
Enrosite Injection for Dogs may be used as the initial dose at 2.5 mg/kg.
It should be administered intramuscularly (IM) as a single dose, followed by initiation of enrofloxacin tablet therapy.
Enrosite Injection for Dogs may be administered as follows:
*The initial Enrosite Injection for Dogs administration should be followed 12 hours later by initiation of enrofloxacin tablet therapy.
Weight Of Animal
Enrosite
™
Injection for Dogs*
2.5 mg/kg
9.1 kg (20 lb)
1.00 mL
27.2 kg (60 lb)
3.00 mL
The lower limit of the dose range was based on efficacy studies in dogs where enrofloxacin was administered at 2.5 mg/kg twice daily. Target animal safety and toxicology studies were used to establish the upper limit of the dose range and treatment duration.
INTRAMUSCULAR
FDA application 200-513
Enroflox Injection for Dogs may be used as the initial dose at 2.5 mg/kg. It should be administered intramuscularly (IM) as a single dose, followed by initiation of enrofloxacin tablet therapy.
Enroflox Injection for Dogs may be administered as follows:
*The initial Enroflox Injection for Dogs administration should be followed 12 hours later by initiation of enrofloxacin tablet therapy.
Weight Of Animal
Enroflox
®
Injection for Dogs*
2.5 mg/kg
9.1 kg (20 lb)
1.00 mL
27.2 kg (60 lb)
3.00 mL
The lower limit of the dose range was based on efficacy studies in dogs where enrofloxacin was administered at 2.5 mg/kg twice daily. Target animal safety and toxicology studies were used to establish the upper limit of the dose range and treatment duration.
INTRAMUSCULAR
FDA application 200-513
Baytril Injectable Solution may be used as the initial dose at 2.5 mg/kg. It should be administered intramuscularly (IM) as a single dose, followed by initiation of Baytril Tablet therapy.
Baytril Injectable Solution may be administered as follows:
*The initial Baytril Injectable administration should be followed 12 hours later by initiation of Baytril Tablet therapy.
Weight
of
Animal
Baytril
Injectable
Solution*
2.5 mg/kg
9.1 kg
(20 lb)
1.00 mL
27.2 kg
(60 lb)
3.00 mL
The lower limit of the dose range was based on efficacy studies in dogs where enrofloxacin was administered at 2.5 mg/kg twice daily. Target animal safety and toxicology studies were used to establish the upper limit of the dose range and treatment duration.
INTRAMUSCULAR
FDA application 140-913
Shake well before each use.
Tilt head so that the affected ear is presented in an upward orientation. Administer a sufficient quantity of Enrofloxacin and Silver Sulfadiazine Otic Emulsion to coat the aural lesions and the external auditory canal.
As a general guide, administer 5-10 drops per treatment in dogs weighing 35 lbs. or less and 10-15 drops per treatment in dogs weighing more than 35 lbs. Following treatment, gently massage the ear so as to ensure complete and uniform distribution of the medication throughout the external ear canal. Apply twice daily for a duration of up to 14 days.
AURICULAR (OTIC)
Enrofloxacin and Silver Sulfadiazine Otic Emulsion(enrofloxacin/silver sulfadiazine)Antibacterial-Antimycotic Emulsion
Enrofloxacin 100 Injection provides flexible dosages and durations of therapy. Enrofloxacin 100 Injection may be administered as a single dose for one day for treatment and control of BRD (cattle), for treatment and control of SRD or for control of colibacillosis (swine), or for multiple days for BRD treatment (cattle). Selection of the appropriate dose and duration of therapy for BRD treatment in cattle should be based on an assessment of the severity of the disease, pathogen susceptibility and clinical response.
SUBCUTANEOUS, INTRAMUSCULAR
FDA application 200-495
Administer 2.5 mg/kg as a single dose, followed by initiation of enrofloxacin tablet therapy
Intramuscular
Federal law restricts this drug to use by or on the order of a licensed veterinarian
Enrofloxacin Antibacterial Injectable Solution
DOSAGE AND ADMINISTRATION:
ORAL
Enroquin® (enrofloxacin)Flavored Tablets